Siliconizing Fluids
Thermo Scientific™ Water-Soluble Siliconizing Fluid
To siliconize glass surfaces use Thermo Scientific™ Water-Soluble Siliconizing Fluid.
Thermo Scientific™ Hydrocarbon Soluble Siliconizing Fluid
For siliconizing glass surfaces use Thermo Scientific™ Hydrocarbon Soluble Siliconizing Fluid.
Med Vet International Miltex Friction Grip Tungsten Carbide Bur, Crosscut Fissure Straight, 10 Pack, Dfg556
Miltex diamond burs come in a variety of shapes and grits for more flexibility for procedures. Diamond particles are uniform in coverage for optimal cutting performance. Crosscut fissure straight. 10 pack. 556.
Medchemexpress LLC (E)-AG 556 (E)-Tyrphostin AG 556 | 133550-41-1 | 99.9% | 336.39 g/mol | C20H20N2O3 | 50 MG
(E)-AG 556 is a small-molecule research compound that selectively inhibits the epidermal growth factor receptor (EGFR) and reduces LPS-induced tumor necrosis factor-alpha (TNF-α) production. It is supplied as a high-purity solid intended for biochemical and cellular studies of EGFR signaling and inflammation pathways.
- Highly selective EGFR inhibitor.
- Reduces LPS-induced TNF-α production in cellular assays.
- High purity suitable for research applications.
- Characterized chemical with CAS 133550-41-1 for unambiguous identification.
- Supplied in a small-pack solid form for laboratory use.
eMolecules Oakwood Chemicals Glycerin USP grade 20kg 480152364 102072 0 000 56-81-5 MFCD00004722 92 094 C3H8O3
Oakwood Chemicals Glycerin USP grade 20kg 480152364 102072 0 000 56-81-5 MFCD00004722 92 094 C3H8O3
Apexbio Technology LLC PMX 205 Trifluoroacetate 514814-49-4 (free base) 500ug
PMX 205 Trifluoroacetate is a cyclic hexapeptide antagonist targeting the complement C5a receptor (C5aR CD88) It is designed to competitively inhibit C5a binding to its receptor thereby modulating complement-mediated inflammatory pathways PMX 205 Trifluoroacetate exerts its biological activity primarily through competitive antagonism at C5aR reducing downstream inflammatory cellular responses In animal models PMX 205 Trifluoroacetate demonstrates anti-inflammatory effects Based on these pharmacological properties PMX 205 Trifluoroacetate holds research potential in the study of neuroinflammation Alzheimer s disease and chemically induced colitis
Medchemexpress LLC (E)-AG 556 | 133550-41-1 | >98.0% | 336.39 g/mol | C20H20N2O3 | 25 MG
(E)-AG 556 is a research-grade small molecule that selectively inhibits epidermal growth factor receptor (EGFR) activity and has been reported to block lipopolysaccharide (LPS)-induced tumor necrosis factor-α (TNF-α) production. It is supplied as a solid powder for use in biochemical and cellular assays and is intended for research use only.
- Selective EGFR inhibition for targeted signaling studies.
- Reported to reduce LPS-induced TNF-α production in cellular models.
- Powder form suitable for preparation of stock solutions and dosing.
- High purity appropriate for biochemical and cellular assays.
- Recommended long-term storage at -20°C to preserve stability.
Medchemexpress LLC (E)-Tyrphostin AG 556 | 133550-41-1 | >98.0% | 336.39 g·mol⁻¹ | C20H20N2O3 | 100 MG
(E)-AG 556 is a selective small-molecule inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase used in cell signaling and pharmacology research. It has been shown to inhibit EGFR-dependent signaling and to block lipopolysaccharide (LPS)-induced tumor necrosis factor-alpha (TNF-α) production in cellular assays. Supplied as a purified solid, it is typically prepared as DMSO stock solutions for in vitro experiments.
- Selective inhibitor of EGFR tyrosine kinase.
- Inhibits LPS-induced TNF-α production in cell assays.
- High purity suitable for in vitro research applications.
- Soluble in DMSO for concentrated stock preparation.
- Provided as a solid powder for laboratory use.
Medchemexpress LLC PMX-53 | 219639-75-5 | MFCD07363866 | 99.9% | 896.09 | C47H65N11O7 | 50 MG
PMX-53 is a synthetic peptidic antagonist of the complement C5a receptor (C5aR1/CD88). It is orally active and is used in preclinical research on inflammation, cancer, and atherosclerosis. Reported potency at C5aR1 is approximately 20 nM, and analytical data and storage recommendations are provided with the product documentation.
- Peptidic C5a receptor antagonist.
- Orally active, suitable for in vivo and in vitro studies.
- Potent activity against C5aR1 (IC50 ≈ 20 nM).
- Selective for C5aR1 over C5L2 and C3aR.
- Characterized sequence and molecular weight for analytical use.
- COA available with storage recommendations to preserve stability.